3 results match your criteria: "KPJ Healthcare University CollegeNilai[Affiliation]"
The Crux of the Medicine Prices' Controversy in Pakistan.
Front Pharmacol
August 2017
School of Pharmacy, Monash UniversitySunway City, Malaysia.
Safety and Effectiveness of Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
Front Pharmacol
July 2017
School of Pharmacy, Monash UniversitySunway, Malaysia.
Article Synopsis
- Recent clinical trials indicate that bivalirudin has similar efficacy to heparin for Percutaneous Coronary Intervention (PCI), but provides a better safety profile.
- The analysis included data from 12 randomized controlled trials with over 44,000 subjects, comparing bivalirudin to heparin in patients with angina and acute coronary syndrome.
- While bivalirudin did not significantly reduce all-cause mortality or myocardial infarction compared to heparin, it was associated with a lower risk of major bleeding but a higher risk of stent thrombosis.
Drug Utilization on Neonatal Wards: A Systematic Review of Observational Studies.
Front Pharmacol
February 2017
Department of Pharmacy Practice, Faculty of Pharmacy, Universiti Teknologi MARASelangor, Malaysia; School of Pharmacy, KPJ Healthcare University CollegeNilai, Negeri Sembilan, Malaysia.
Article Synopsis
- There is limited evidence regarding the safety and efficacy of drug use in neonates, yet medications are widely used in this population, prompting a systematic review of drug utilization in hospitalized infants.
- The literature review, covering studies published until August 2016, included 20 drug utilization studies from various countries, with a focus on different drug classes, particularly antimicrobials.
- The findings revealed considerable variability in study design and reporting methods, with anti-infectives being the most commonly reported drugs, particularly ampicillin and gentamicin as the leading antimicrobials prescribed for hospitalized neonates.